A 99.66 percent majority of Bayer’s shareholders have approved the planned spin-off of Lanxness, which is taking over the German company’s basic specialty and fine chemicals operations as well as the manufacture of rubber, polyurethane and other polymers that have a reached a certain maturity. Each shareholder of Bayer will ...
Your membership benefits:
If you aren’t ready to subscribe now, choose the 30 day trial for 1€. To continue reading this article REGISTER NOW.